On Stockhead today, There’s a reason our investment bank of the week is called Goldman Sachs.

The gold team at GS just put out some rather toppy forecasts for 2024 gold prices and beyond and has pegged ASX diggers, Evolution, Regis Resources and Gold Road Resources as standouts.

The call is beyond US$2130/oz in 2024 according to our Josh Chiat, who says ‘easing inflationary pressures and improved hedge books could see margins in the ASX gold sector lift $300/oz by 2025.’

Josh has the story, while Bevis outs the ASX players stepping on the gas, and Reubs runs the ruler over the resources companies that won June.

But first, the day ahead.



The following stocks went into trading halts Tuesday and are expected out in the coming days:

Ardea Resources (ASX:ARL) – Pre-Feasibility Study from the Kalgoorlie nickel project Goongarrie Hub.

Godolphin Resources (ASX:GRL) – Capital raising.

Hexagon Energy Materials (ASX:HXG) – Response to ASX queries about the WAH2 Project Preliminary Feasibility Study.




Gold: $US1930.20 (+0.45%)

Silver: $US23.01 (+0.57%)

Nickel (3mth): $US24,025/t (+2.02%)

Copper (3mth): $US9002.50/t (+0.27%)

Oil (WTI): $US70.54 (+1.09%)

Oil (Brent): $US75.23 (+0.97%)

Iron 62pc Fe: $US111.50/t (-1.76%)

AUD/USD: 0.6686  (+0.24%)

Bitcoin: $US30,983 (+0.46%)



Maiden Resource. Falcon Lake Lithium.

Keep up to date with Stockhead coverage or you’ll miss gold like that EVERY DAY. Follow our Twitter page.

For all you crypto lovers Stockhead’s Coinhead Facebook group is the place to share your views, insights, tips and ideas.

Also, be sure to check in preopen each day for ‘Market highlights and 5 ASX small caps to watch’, and 10.30am for our daily ‘10 at 10’ column — a live summary of winners & losers at the opening bell.



Here are the best performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin

Some standouts:

Mount Burgess Mining (ASX:MTB) +350% > on no particular news.

RightCrowd (ASX:RCW): +175% > on the proposal from the firm of a divestment of its physical security businesses for $13.5 million and “repositions into the identity and cyber security markets”.

Atomo Diagnostics (ASX:AT1): +122% > on a price movement clarification that wasn’t super clear… “Atomo advises that it is not aware of any information that has not been announced to the market which, if by known by some in the market, could explain the recent trading in its securities.”

That said… Atomo’s share price is likely up a la Lumos Diagnostics (ASX:LDX) (see Monday). This on Tuesday from Atomo:

“Atomo’s partner, Lumos Diagnostics announced to the market that it has received US FDA approval for its FebriDx test, which utilises Atomo’s user friendly integrated Pascal test platform, making Atomo a critical supplier to Lumos for this approved product.”

So there’s that.



Here are the worst performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin